SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-16-122091
Filing Date
2016-05-19
Accepted
2016-05-19 16:07:17
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 a16-11674_1424b5.htm 424B5 385035
2 GRAPHIC g116741bui001.jpg GRAPHIC 2003
3 GRAPHIC g116741bui002.jpg GRAPHIC 6734
4 GRAPHIC g116741bci001.gif GRAPHIC 2211
5 GRAPHIC g116741bci002.jpg GRAPHIC 34324
  Complete submission text file 0001104659-16-122091.txt   449061
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-192640 | Film No.: 161663274
SIC: 2835 In Vitro & In Vivo Diagnostic Substances